Translational molecular imaging in exocrine pancreatic cancer

Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon aft...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of nuclear medicine and molecular imaging Vol. 45; no. 13; pp. 2442 - 2455
Main Authors Cornelissen, Bart, Knight, James C., Mukherjee, Somnath, Evangelista, Laura, Xavier, Catarina, Caobelli, Federico, Del Vecchio, Silvana, Rbah-Vidal, Latifa, Barbet, Jacques, de Jong, Marion, van Leeuwen, Fijs W. B.
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2018
Springer Nature B.V
Springer Verlag (Germany) [1976-....]
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Effective treatment for pancreatic cancer remains challenging, particularly the treatment of pancreatic ductal adenocarcinoma (PDAC), which makes up more than 95% of all pancreatic cancers. Late diagnosis and failure of chemotherapy and radiotherapy are all too common, and many patients die soon after diagnosis. Here, we make the case for the increased use of molecular imaging in PDAC preclinical research and in patient management.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1619-7070
1619-7089
DOI:10.1007/s00259-018-4146-5